Showing 1241-1250 of 3082 results for "".
Connect with Caution: Avoiding Social Media Pitfalls
https://practicaldermatology.com/topics/practice-management/connect-with-caution-avoiding-social-media-pitfalls/21498/New Products
https://practicaldermatology.com/columns/new-products/new-products-2/23356/Can Dupilumab Improve Keloid Scarring?
https://practicaldermatology.com/topics/skin-of-color/can-dupilumab-improve-keloid-scarring/23820/Coming Soon: New Biopsy Codes
https://practicaldermatology.com/topics/general-topics/coming-soon-new-biopsy-codes/20411/Is your practice prepared for changes to the CPT codes?Skin Cancer Is Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-cancer-emisem-cancer/21341/Of Pandemics and Postponements
https://practicaldermatology.com/topics/practice-management/of-pandemics-and-postponements/23342/Take 5: Strategies for Optimal Outcomes with Dermal Fillers
https://practicaldermatology.com/columns/take-5/take-5-strategies-for-optimal-outcomes-with-dermal-fillers/21949/A dermatologic surgeon's tips for getting the most from dermal fillers and improving patient satisfaction.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-33/23690/Valeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of ImlygicOn the Leading Edge, Not the Bleeding Edge: Joe Niamtu, DMD
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/on-the-leading-edge-not-the-bleeding-edge-joe-niamtu-dmd/18606/Innovator, influencer, and podium perennial Joe Niatmu, III, DMD has built a successful surgical aesthetic practice by focusing on the basics, concentrating on his strengths, and avoiding passing fads. How does he stay passionate, spot the best new developments, and build a fulfilling practice? In t